Target intelligence / Profile preview

N-acyl taurine (NAT)

Target
NAT
Molecular classification
Bioactive lipid, N-acyl amide, Signaling molecule, Metabolite
01

Overview

N-acyl taurines (NATs) are a family of endogenous bioactive lipids consisting of a long-chain fatty acid tail N-linked to the amino group of the amino acid taurine [1]. These molecules function as signaling ligands that modulate the activity of several membrane proteins, most notably the Transient Receptor Potential (TRP) ion channels, specifically TRPV1 and TRPV4 [2]. By activating these channels, NATs participate in calcium signaling and sensory transduction related to pain and inflammation [4]. Beyond sensory roles, certain NAT species have been identified as endogenous chemical uncouplers of mitochondrial respiration, a process regulated by the enzyme PM20D1, which catalyzes their synthesis and hydrolysis [3]. This uncoupling activity indicates a significant role for NATs in systemic energy expenditure and thermogenesis, making them relevant to metabolic health [6]. Additionally, NATs have been observed to stimulate insulin secretion from pancreatic beta cells, further highlighting their importance in glucose homeostasis [5]. While NATs are bioactive metabolites rather than direct protein targets themselves, the enzymes that regulate their levels (such as FAAH and PM20D1) and the receptors they activate are major areas of investigation for treating obesity, type 2 diabetes, and chronic pain [3][5].

Other names
N-acyltaurinesFatty acid tauridesTaurine-conjugated fatty acidsN-acyl-taurines
02

Mechanism of action

N-acyl taurines act as endogenous agonists for Transient Receptor Potential (TRP) ion channels, specifically TRPV1 and TRPV4, and function as chemical uncouplers of mitochondrial oxidative phosphorylation to increase energy expenditure.

03

Biological functions

Signal transductionCalcium signalingMitochondrial uncouplingInsulin secretionThermogenesisSensory transduction
04

Disease associations

Type 2 diabetesObesityPainInflammationMetabolic syndrome
05

Safety considerations

Potential for off-target effects across multiple TRP channel family membersSystemic thermoregulatory disruptionComplexity of lipid signaling crosstalk in metabolic pathways
06

Interacting drugs

FAAH inhibitors (e.g., PF-04457845)

2 more in the full profile.

07

Biomarkers

Circulating N-acyl taurine levelsPM20D1 enzymatic activityTRPV1 expression levelsFAAH activity

Beyond the preview

Go deeper on N-acyl taurine (NAT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-acyl taurine (NAT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call